Snag This Deal Even Lower Than Director Strobeck Did
March 23, 2020 at 10:26 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 18, Accelerate Diagnostics Inc's Director, Matthew Strobeck, invested $71,100.00 into 10,000 shares of AXDX, for a cost per share of $7.11..